Fish Oil (Long-Chain Omega-3 EPA / DHA, Marine Source)
Fish oil supplements deliver long-chain marine omega-3 fatty acids — EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) — pressed from oily fish (anchovy, sardine, mackerel, herring, salmon) or extracted from cod liver. EPA and DHA carry several authorised UK food-supplement health claims under Regulation 1924/2006 (retained) at specified dose thresholds: DHA 250 mg/day for brain and vision; EPA+DHA 250 mg/day for heart; EPA+DHA 3 g/day for blood pressure and 2 g/day for triglycerides; DHA 200 mg/day for maternal contribution to foetal / infant brain development. These authorised claims are about maintaining normal function, NOT about preventing cardiovascular disease — NICE (NG238) does not recommend omega-3 supplements to prevent CVD. Quality is the load-bearing axis — peroxide value, TOTOX, molecular distillation, and heavy-metal / PCB panels on CoA are mandatory. Cod liver oil specifically is to be AVOIDED in pregnancy (retinol). Fish allergen.
Camden Medicals editorial · Last reviewed 12 June 2026 · Next review December 2026
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Fatty acid
- Top use evidence
- Strong
On this page
What it is
Fish oil is the oil extracted from the body or liver of oily fish — most commercial supplement-grade material comes from anchovy, sardine, mackerel, herring, or Alaskan pollock (body oil), or from cod liver (liver oil). The two principal long-chain omega-3 polyunsaturated fatty acids of nutritional interest are eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3). EPA and DHA are synthesised primarily by marine microalgae and concentrate up the marine food chain through plankton, small fish, and into larger predator fish — the higher up the food chain, the more contamination accumulates alongside the omega-3 content, which is the editorial reason small-fish sourcing (anchovy, sardine) tends to deliver cleaner CoAs than larger predator-fish sources.
The form of EPA / DHA in commercial supplements matters. "Triglyceride (TG) form" fish oil retains the natural triglyceride backbone of the fatty acids and is generally better absorbed than the "ethyl ester (EE) form" used in higher-concentration concentrates. EE form is produced by transesterifying the natural triglycerides with ethanol; this allows the manufacturer to concentrate EPA / DHA to 60–90% of the oil (versus ~30% in unconcentrated TG fish oil) but the EE form is more oxidation-prone and somewhat less bioavailable per gram. Reconstituted-triglyceride (rTG) is a third form — EE concentrates re-esterified back to the triglyceride backbone — which combines the absorption advantage of TG with the EPA / DHA concentration advantage of EE. Premium supplements declare which form they use.
Cod liver oil is a special case. The liver is the storage organ for fat-soluble vitamins, so cod liver oil naturally contains vitamin A (retinol) and vitamin D in addition to EPA / DHA. The vitamin A content is the load-bearing safety axis in pregnancy — the NHS advises not taking cod liver oil, or any vitamin-A-containing supplement, during pregnancy because too much vitamin A (retinol) can harm the baby. Plain fish-body oil (anchovy / sardine / mackerel) does not contain meaningful retinol and does not carry this pregnancy caveat, although the molecular-distillation and contaminant-panel disclosure remain essential for any pregnancy-context use.
Regulatory note: fish oil is a long-established UK food supplement and is not a UK novel food. UK food-supplement health claims under Regulation 1924/2006 (retained) DO exist for EPA and DHA at specified per-day dose thresholds (see `regulatory.authorised_health_claims_uk` below). Marketing copy that uses these exact authorised wordings, at products that meet the per-day dose threshold, is lawful UK claim language. Marketing copy that paraphrases the authorised wording, or invokes endpoints outside the authorised list, is NOT lawful — common drift includes "anti-inflammatory", "joint health", "skin health", and "immune support" framing on fish oil, none of which are authorised UK food-supplement claim wording.
At a glance
- Fish oil contains the long-chain marine omega-3s EPA and DHA — distinguishing it from short-chain plant omega-3 (alpha-linolenic acid in flaxseed, walnuts) which converts only inefficiently to EPA / DHA in human metabolism. Per-serving EPA + DHA milligrams (NOT just bulk fish-oil milligrams) is the load-bearing label disclosure.
- AUTHORISED UK food-supplement health claims exist for EPA / DHA at specified thresholds: DHA 250 mg/day for brain function and vision; EPA+DHA 250 mg/day for heart function; EPA+DHA 3 g/day for blood-pressure maintenance and 2 g/day for blood-triglyceride maintenance (both within the 5 g/day supplemental intake EFSA found not to raise safety concerns); DHA 200 mg/day (maternal intake) for foetal / infant brain and eye development. These wordings are the ONLY UK-legal claim language and must be invoked verbatim. They describe maintaining NORMAL function — they are not disease-prevention claims.
- Quality is the load-bearing axis. Fish oil is oxidation-prone and bioaccumulates marine contaminants. Look for: peroxide value (PV) below 5 mEq/kg; anisidine value (AV) below 20; TOTOX (= 2×PV + AV) below 26 — these are the GOED voluntary standards. Molecular distillation should be declared. Heavy-metal panel (mercury, lead, cadmium, arsenic), PCB panel, dioxin panel — all on CoA.
- Triglyceride (TG) form vs ethyl ester (EE) form: TG fish oil (the "natural" reconstituted-triglyceride form) is generally better absorbed than EE concentrates and less oxidation-prone. EE concentrates allow higher EPA / DHA per softgel at lower cost. Both are lawful UK supplements; the TG form is the premium-quality marker.
- Cod liver oil specifically is to be AVOIDED in pregnancy because of its vitamin A (retinol) content — the NHS advises not taking cod liver oil or any vitamin-A-containing supplement in pregnancy, as too much vitamin A can harm the baby. (For context, a single 1 g cod liver oil softgel can deliver several hundred micrograms of retinol, and the adult reference intake is only 600–700 µg/day.) Plain fish-body oil (anchovy / sardine / mackerel) is low in retinol, does NOT carry this caveat, and is acceptable in pregnancy with molecular-distillation and contaminant-panel verification.
- Fish allergen — fish is one of the 14 UK FIC declared allergens. Customers with fish allergy must avoid; cross-reactivity with crustacean and mollusc allergy is variable but conservative reading is to avoid all marine-source supplements if any documented seafood allergy. Vegan / vegetarian customers should choose algal-source omega-3 (vegan-omega-3) instead.
- Anticoagulant interaction — well documented at ≥2 g/day combined EPA+DHA. Disclose use to your anticoagulation team if you take warfarin, DOACs, aspirin, clopidogrel, or NSAIDs. Surgical pause is standard practice (typically 7–14 days pre-op).
What people use it for
Adults whose oily-fish intake falls below NHS guidance (1 portion of oily fish per week)
NHS guidance is to eat at least one portion (about 140 g cooked) of oily fish a week; oily fish supplies the long-chain omega-3s EPA and DHA. The British Dietetic Association notes that omega-3 supplements are not recommended for the general UK population because the evidence of added benefit is inconclusive, and that food sources come first. For adults whose oily-fish intake is below the guidance and who choose a supplement, a product delivering 250 mg/day combined EPA + DHA meets the threshold for the authorised heart, brain, and vision claim wording. The authorised claims describe maintenance of normal function, not disease prevention. [1,2]
StrongPregnant and breastfeeding women seeking the maternal-omega-3 contribution to foetal / infant brain development
Authorised UK food-supplement health claims: maternal intake of 200 mg DHA/day (in addition to the recommended adult intake) contributes to the normal brain development, and to the normal eye development, of the foetus and breastfed infants. Supplement-grade molecular-distilled fish-body oil (anchovy / sardine / mackerel) at this dose is acceptable in pregnancy — but the NHS advises NOT to take cod liver oil or any supplement containing vitamin A (retinol) in pregnancy, because too much vitamin A can harm the baby. Plain fish-body oil and cod liver oil are not interchangeable in pregnancy. [3,2]
StrongAdults seeking heart-function support at the authorised omega-3 threshold
Authorised UK food-supplement health claim: EPA and DHA contribute to the normal function of the heart at 250 mg/day combined intake. A supplement at or above this threshold can lawfully invoke the claim wording. This is a normal-function maintenance claim, NOT a claim that fish oil prevents cardiovascular disease — NICE (NG238) does not recommend omega-3 supplements to prevent CVD. The further authorised claims need higher doses: blood pressure at 3 g/day and blood triglycerides at 2 g/day combined EPA + DHA. Typical 1000 mg fish-oil softgels deliver roughly 300 mg combined EPA + DHA, so those higher-dose claims require multi-softgel regimens or a higher-concentration product. [2,4]
Strong
How it works
EPA and DHA are incorporated into cell-membrane phospholipids where they alter membrane fluidity, modulate membrane-bound receptor and ion-channel behaviour, and serve as substrates for resolvin and protectin lipid mediators that participate in the resolution phase of inflammation. EPA in particular competes with arachidonic acid for cyclooxygenase and 5-LOX pathways, shifting the eicosanoid mix toward less pro- inflammatory and pro-aggregatory mediators. The cardiovascular- function authorised claim sits on this mechanistic basis — the 250 mg/day combined EPA + DHA threshold reflects EFSA's consensus position on the dose at which the claim wording is substantiated. The brain-function and vision claims for DHA at 250 mg/day reflect DHA's high concentration in retinal photoreceptor and synaptic membrane phospholipids. The blood-pressure claim (3 g/day) and triglyceride claim (2 g/day) reflect the higher-dose pharmacological effect distinct from the nutritional-physiology lower-dose claims.
Common myths
Myth""More milligrams of fish oil is better.""
RealityBulk fish oil milligrams tell you the softgel size, not the omega-3 content. A "high-strength 1500 mg fish oil" softgel might deliver only 250 mg combined EPA + DHA if it's low-concentration TG-form oil. Look for the EPA milligrams and DHA milligrams declared per serving — those are the regulatorily relevant figures and the basis for the authorised health claims. Per-day EPA + DHA combined is what counts.
Myth""Fish oil is anti-inflammatory and good for joints.""
RealityAnti-inflammatory and joint-health claims are NOT authorised UK food-supplement claim wording for fish oil. NICE rheumatoid-arthritis guidance does not list fish oil; the trial evidence on joint endpoints is mixed. UK supplement marketing must stay within the authorised heart, brain, vision, blood-pressure, and triglyceride wordings. People with diagnosed inflammatory arthritis should follow NICE-guided care, not substitute fish oil for prescribed therapy. [5]
Myth""Cod liver oil is the best fish oil because it's traditional.""
RealityCod liver oil is a different product from plain fish-body oil — the liver concentrates fat-soluble vitamins, so cod liver oil contains vitamin A (retinol) and vitamin D in addition to EPA / DHA. The retinol content is a meaningful safety consideration in pregnancy: the NHS advises not taking cod liver oil or any vitamin-A-containing supplement while pregnant, because too much vitamin A can harm the baby. For pregnancy, plain fish-body oil — anchovy / sardine / mackerel source — is the safer choice. For non-pregnant adults the choice is partly a matter of whether you want the vitamin A and D loading bundled in. [3]
Myth""Plant-source omega-3 (flaxseed, chia, walnuts) is the same as fish oil.""
RealityPlant-source omega-3 is short-chain alpha-linolenic acid (ALA, 18:3 n-3), not the long-chain EPA and DHA in fish oil. Human metabolism converts ALA to EPA and DHA only inefficiently — typical conversion rates are 5–10% for EPA and <1% for DHA. The authorised UK heart, brain, and vision claims apply specifically to EPA and DHA, not to ALA. Plant-source omega-3 supplementation does not lawfully invoke those claims at any dose.
Myth""Fishy burps mean it's working.""
RealityFishy burps mean the oil has oxidised somewhere between manufacture and ingestion. Fresh, well-formulated fish oil with low peroxide value (under 5 mEq/kg) and proper antioxidant carrier (vitamin E mixed tocopherols) should not cause significant fishy reflux. Persistent fishy burps suggest a quality problem — check the CoA peroxide / TOTOX figures and consider switching to a fresher product or to enteric-coated softgels.
Myth""Fish oil thins the blood, so taking aspirin is overkill.""
RealityFish oil at supplement doses (≥2 g/day combined EPA+DHA) does have antiplatelet effect, but it is NOT a substitute for prescribed antiplatelet medication. People prescribed aspirin, clopidogrel, ticagrelor, warfarin, or DOACs are on those medications for specific clinical reasons documented by their prescriber. Fish oil should be disclosed to the anticoagulation team — combined antiplatelet effect can raise bleeding risk — but it does not substitute for prescribed therapy.
⚖️ The official position
What may lawfully be claimed about Fish Oil (Long-Chain Omega-3 EPA / DHA, Marine Source) in Great Britain. This is a regulatory position, not an evidence grade.
A health claim is authorised in Great Britain.
“EPA and DHA contribute to the normal function of the heart”
“DHA contributes to maintenance of normal brain function”
“DHA contributes to maintenance of normal vision”
“EPA and DHA contribute to maintenance of normal blood pressure”
“EPA and DHA contribute to maintenance of normal blood triglyceride concentrations”
“Maternal intake of DHA contributes to the normal brain development of the foetus and breastfed infants”
“Maternal intake of DHA contributes to the normal development of the eye of the foetus and breastfed infants”
This claim is authorised for use in Great Britain under the GB Nutrition and Health Claims regulation. A product may carry it when it provides at least 15% of the UK NRV per recommended daily portion.
Authorised UK health claims
Verbatim from the GB Nutrition and Health Claims Register (Reg 432/2012 as assimilated in GB). A product can carry these claims when it provides at least 15% of the UK NRV per recommended daily portion.
7 authorised claims — show / hide
- "EPA and DHA contribute to the normal function of the heart"
- "DHA contributes to maintenance of normal brain function"
- "DHA contributes to maintenance of normal vision"
- "EPA and DHA contribute to maintenance of normal blood pressure"
- "EPA and DHA contribute to maintenance of normal blood triglyceride concentrations"
- "Maternal intake of DHA contributes to the normal brain development of the foetus and breastfed infants"
- "Maternal intake of DHA contributes to the normal development of the eye of the foetus and breastfed infants"
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Heart, brain and vision — maintenance of normal function (authorised UK claim category)
StrongEvidencestrongUK and EU guidance leads. The GB Nutrition and Health Claims Register, drawing on EFSA scientific opinions, authorises a defined set of EPA / DHA claims at set doses: EPA and DHA contribute to the normal function of the heart (250 mg/day combined); DHA contributes to maintenance of normal brain function and of normal vision (250 mg/day DHA each — these are DHA-only, so a high-EPA / low-DHA product at 250 mg/day combined may not reach the DHA threshold); and EPA + DHA contribute to maintenance of normal blood pressure (3 g/day) and normal blood triglycerides (2 g/day), both within the 5 g/day supplemental intake EFSA found not to raise safety concerns. These are normal-function maintenance claims — NICE (NG238, 2023) does NOT recommend omega-3 supplements to prevent cardiovascular disease, so "heart protection" or "cardiovascular health" framing is both outside the authorised wording and against current UK guidance. Beneath that guidance, the research Camden reviewed is consistent with the conservative reading: large outcome trials of omega-3 supplements for CVD prevention have been mixed, which is why the UK position rests on the narrower normal-function claims rather than a disease-prevention claim. [2,4]
Inflammatory and joint conditions (NOT authorised; commonly drifted)
InsufficientEvidenceinsufficientUK guidance leads, and it does not support this use: NICE rheumatoid-arthritis guidance (NG100) does not list fish oil among recommended interventions, and there is no authorised GB food-supplement claim for joint or anti-inflammatory benefit. Beneath that, the research Camden reviewed is mixed — trials on inflammatory and joint endpoints have not produced a consistent effect, and no high-quality systematic review establishes fish oil as a treatment. UK copy must not invoke joint-pain relief, anti-inflammatory, or arthritis-treatment language. People with diagnosed inflammatory arthritis should follow NICE-guided care rather than substitute a supplement for prescribed therapy. [5]
Mood and depression
InsufficientEvidenceinsufficientUK guidance leads and is cautionary: NICE depression guidance (NG222, 2022) does not list fish oil among recommended interventions, and fish oil is not a UK-recognised treatment for any mood disorder. Beneath that, the research Camden reviewed shows a mixed picture — some meta-analyses report a modest signal at high-EPA-fraction doses (around 1 g EPA/day with EPA greater than DHA), but the finding is inconsistent across larger and more recent trials. UK supplement copy must not invoke mood, depression, or antidepressant-adjunct claim language; anyone considering this should speak to their GP and not stop prescribed medication. [6]
Dry eye syndrome
InsufficientEvidenceinsufficientUK guidance leads: NICE and NHS dry-eye information do not list fish oil as a treatment, and the authorised eye-related claim is limited to the DHA / normal-vision wording at 250 mg/day, not a dry-eye treatment claim. Beneath that, the research Camden reviewed points the same way — earlier, smaller trials suggested a modest symptom benefit, but the large, well-conducted DREAM trial (New England Journal of Medicine, 2018, 535 participants) found no benefit over placebo. UK supplement copy must not invoke dry-eye treatment claim language.
Safety
Pregnancy and breastfeeding
Plain fish-body oil supplements (anchovy / sardine / mackerel source) providing around 200 mg DHA/day are acceptable in pregnancy, and the authorised maternal-DHA claim wording reflects the foetal / infant brain- and eye-development contribution. Molecular distillation and contaminant-panel verification are mandatory in pregnancy context. COD LIVER OIL is to be AVOIDED in pregnancy: the NHS advises not taking cod liver oil or any vitamin-A-containing supplement while pregnant, because too much vitamin A (retinol) can harm the baby. Plain fish-body oil and cod liver oil are not interchangeable in pregnancy. Speak to your GP, midwife, or pharmacist before taking any supplement in pregnancy.
Plain fish-body oil at 200 mg DHA/day supports the maternal-DHA-to-breast-milk pathway and the authorised claim wording covers this. Molecular-distilled, low-contaminant supplement-grade material is the appropriate choice. Cod liver oil is more conservative to avoid in lactation also.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
Contraindications
- Documented fish allergy — avoid all fish-source omega-3 supplements; choose algal-source vegan-omega-3 instead.
- Documented mussel / crustacean allergy with cross-reactivity confirmed by allergist — conservative reading is to avoid all marine-source supplements pending clearance.
- Use within 7–14 days of major surgery — antiplatelet effect at supplement doses warrants peri-operative pause.
- Cod liver oil specifically: pregnancy (the NHS advises avoiding cod liver oil and vitamin-A-containing supplements while pregnant), and concurrent use of other vitamin-A-containing supplements (additive retinol load).
Drug interactions
- Anticoagulants (warfarin, DOACs) and antiplatelets (aspirin, clopidogrel, ticagrelor, NSAIDs): combined antiplatelet effect at ≥2 g/day combined EPA + DHA. Disclose use to your anticoagulation team and pause 7–14 days pre-major-surgery.
- Antihypertensive medications: at high doses (≥2 g/day), fish oil contributes a small additive blood-pressure-lowering effect. Not a contraindication; disclose at GP review.
- Statins: no clinically meaningful interaction at typical supplement doses; high-dose fish oil and statins can be combined under prescriber supervision (the prescription-strength omega-3 product Vascepa / icosapent ethyl is a different product entirely).
- Vitamin A supplements: COD LIVER OIL specifically adds to the retinol load from any separate vitamin A supplementation, which matters most in pregnancy and for long-term high intake; plain fish-body oil does not carry this interaction.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Fishy reflux / aftertaste / burps — typically signals partial oxidation. Check product freshness; consider switching to enteric-coated softgels or storing in the refrigerator.
- Mild gastrointestinal upset (nausea, soft stool) at higher per-day doses.
Rare side effects
- Allergic reaction in fish-allergic individuals — ranges from mild urticaria to anaphylaxis.
- Increased bleeding tendency at ≥2 g/day combined EPA + DHA, particularly with concurrent antiplatelet medication.
- Vitamin A excess if cod liver oil is consumed alongside other vitamin-A-containing supplements — the NHS advises against high vitamin A intake from supplements over time. Plain fish-body oil does not carry this risk.
How to take it
- Timing
- Take with food (the oil is fat-soluble; food co-intake supports absorption and reduces fishy reflux). Splitting the daily dose across two meals is reasonable for multi-softgel regimens.
How to spot quality
Look for
- Per-serving EPA milligrams AND DHA milligrams declared on the label and CoA — not just bulk fish-oil milligrams. The authorised UK health claims are anchored to these figures, not to bulk oil weight.
- Source species declared — small-fish sourcing (anchovy, sardine, mackerel, herring) gives cleaner contaminant profiles than larger predator-fish sources. Sustainability certifications (MSC, Friend of the Sea, IFFO RS) are positive markers.
- Form declared — triglyceride (TG), reconstituted triglyceride (rTG), or ethyl ester (EE). TG and rTG are generally better-absorbed and less oxidation-prone; EE allows higher concentration. All three are lawful UK supplements; disclosure is the quality marker.
- Molecular distillation step declared on the CoA — this is the standard purification removing mercury, PCBs, dioxins, PFAS. Without this disclosure, contaminant levels cannot be assumed.
- Oxidation panel on the CoA: peroxide value (PV) below 5 mEq/kg; anisidine value (AV) below 20; TOTOX (= 2×PV + AV) below 26. These are GOED voluntary standards for fresh, well-stabilised supplement-grade fish oil.
- Heavy-metal panel on the CoA — mercury, lead, cadmium, arsenic. EC Regulation 629/2008 (retained in GB) sets bivalve cadmium limits but fish-oil-specific limits come via the GOED voluntary standards (mercury < 0.1 ppm).
- PCB and dioxin panel on the CoA — total PCBs, sum of dioxins + dioxin-like PCBs in pg WHO-TEQ/g. EU dietary limits for dioxins are tight; molecular-distilled supplement-grade material should sit well below them.
- Antioxidant carrier declared (vitamin E as mixed tocopherols, rosemary extract, ascorbyl palmitate). Without antioxidant protection, fish oil oxidises rapidly.
- Capsule-shell type declared — gelatin softgels are not vegetarian / vegan; modified-starch + carrageenan softgels are vegan but uncommon for fish-source oils (algal-source omega-3 in vegan-omega-3 is the vegan path).
Red flags
- Generic "Omega 3 Fish Oil 1000 mg" without per-serving EPA + DHA milligrams declared.
- Anti-inflammatory, joint-health, immune-support, mood, dry-eye, or skin-health marketing language not authorised under UK Regulation 1924/2006 (only the specific heart, brain, vision, blood-pressure, triglyceride, and maternal-DHA wordings are authorised).
- Cod liver oil sold without explicit "AVOID IN PREGNANCY — contains vitamin A" warning on label.
- Per-day dose recommendations above 5 g combined EPA + DHA without clinical-supervision context.
- Absence of TOTOX / peroxide-value figures on CoA, or absence of heavy-metal / PCB panels.
- Source species "marine fish" with no specific species disclosure — particularly relevant for predator-fish sources (tuna, swordfish, shark) which carry higher mercury loads.
- Plant-source omega-3 (flaxseed / chia / walnut) sold as equivalent to fish oil — short-chain ALA is biologically not the same as long-chain EPA / DHA.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Vegan Omega-3 (Algal EPA + DHA)
Strong evidenceOmega-3 cluster — algal-source DHA / EPA is the vegan / pescatarian-avoiding alternative to fish oil.
Algal oil delivers DHA + (some products) EPA from microalgae fermentation — same molecules as fish oil without the fish-source supply chain. Same UK Article 13.1 EPA / DHA authorised claim cluster.
Evidence: Same molecules; equivalent UK regulatory tier. [7,8,9]
Doses studied: Use ONE of fish oil OR algal oil — not both at high doses.
Vitamin D3
Moderate evidenceCardiovascular + immune cluster — fish oil EPA/DHA + vitamin D3 both feature in cardiovascular and immune authorised-claim contexts.
Fish oil EPA/DHA: heart, brain, vision UK Article 13.1 claims. Vitamin D3: immune, bone, muscle, calcium homeostasis. Mechanism complementary across two distinct nutrient axes. Cod liver oil delivers both naturally.
Evidence: Authorised UK claims for both. Camden vitamin-d3 NB-537 / NB-476 cluster. [2]
Doses studied: 1000-2000 mg fish oil + 10-25 µg vitamin D3 daily.
Found in Camden: Weekly Vitamin D3 3000IU + K2 MK-7 90 Capsules · Aurifera™ Shilajit Adaptogen Complex 90 Capsules
Vitamin E (alpha-tocopherol)
Moderate evidenceLipid-stability + antioxidant pairing — vitamin E protects fish oil PUFA from peroxidation in storage and in vivo.
α-tocopherol scavenges lipid peroxyl radicals in PUFA-rich membranes / oils. Co-formulation supports oxidative stability. UK Article 13.1 vitamin E cell-protection claim.
Evidence: Mechanism well-established. UK Article 13.1 vitamin E claim authorised. [2]
Doses studied: 1000-2000 mg fish oil + 12 mg vitamin E (often included in fish-oil capsules at low dose).
Evening Primrose Oil (Oenothera biennis)
Limited evidenceOmega-fatty-acid cluster — EPO GLA (n-6) + fish oil EPA / DHA (n-3). Mechanism complementary across n-6 / n-3 axes.
EPO GLA → DGLA → series-1 prostaglandins (anti-inflammatory) at n-6 axis; fish oil EPA → series-3 prostaglandins (anti-inflammatory) at n-3 axis. Different prostaglandin pathways.
Evidence: Both have UK regulatory tier; fish oil has authorised heart / brain / vision claims.
Doses studied: 1000-2000 mg EPO + 1000-2000 mg fish oil daily.
Flaxseed (Linum usitatissimum) — whole seed, oil, and lignans
Moderate evidenceOmega-3 cluster — flaxseed ALA upstream of EPA / DHA conversion (modest in humans, ~5-10%); fish oil delivers EPA / DHA directly.
Flaxseed ALA → EPA → DHA conversion is rate-limited in humans (~5-10% efficient). Direct fish-oil EPA / DHA bypasses the conversion. Vegan / pescatarian ALA reliance vs direct n-3 supply.
Evidence: ALA → EPA conversion mechanism well-established. UK fish-oil EPA / DHA Article 13.1 claims. [10,11,12,13]
Doses studied: 1-2 tbsp ground flaxseed (ALA) + 1000-2000 mg fish oil (EPA/DHA) daily — combined coverage.
Ginkgo Biloba (leaf extract)
Limited evidenceCardiovascular cluster — both have anticoagulant / platelet-modulation signals. CONTRAINDICATION-LEVEL when combined with warfarin.
Ginkgo platelet-activation-factor inhibition; fish oil EPA / DHA platelet aggregation modulation. Additive bleeding risk. CONTRAINDICATION with warfarin / DOACs without anticoagulation-clinic input.
Evidence: Bleeding-risk warning; talk to prescriber.
Doses studied: Combination requires anticoagulation-clinic input if on warfarin / DOAC.
Green-Lipped Mussel (Perna canaliculus)
Limited evidenceOmega-3 cluster — GLM Lyprinol + fish oil — different EPA / DHA delivery contexts.
GLM Lyprinol is a CO2-extracted lipid-fraction with EPA / DHA + ETA + furanoid acids (anti-inflammatory profile). Fish oil bulk EPA / DHA. Different lipid extracts; mechanism overlapping on anti-inflammatory axis.
Evidence: Camden green-lipped-mussel + fish-oil entries cover cluster.
Doses studied: 1000 mg GLM extract + 1000-2000 mg fish oil daily.